Phase 1 trial: T4 immunotherapy of head and neck cancer

Project: Research

Project Details

StatusFinished
Effective start/end date1/03/20151/04/2023

Collaborative partners

Funding

  • Wellcome Trust: £773,419.00
  • Wellcome Trust: £4,320.86